Research Antibodies Market to Generate Heightened Revenue at USD 5.9 billion by 2028

  

Research Antibodies Industry Overview

The global research antibodies market size was estimated at USD 3.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.4% from 2021 to 2028.

Antibodies are proteins made by B cells and are a part of the human body’s immune system. These molecules can bind themselves to specific molecules that make them an ideal probe for cell research purposes. They are also used to isolate and aid in the identification of molecules of interest in cells. Currently, antibodies are one of the most important tools to study the function of a protein in cells. Increasing incidence of neurodegenerative diseases such as Huntington’s disease, Multiple Sclerosis, and Parkinson’s diseases is further encouraging research activities in neurobiology. A rise in the geriatric population and lack of available treatments has also led to a substantial rise in the demand for research antibodies to develop personalized medicines, advanced therapeutics, and novel and effective treatments.

The outbreak of COVID-19 has created lucrative opportunities in the market. Several pharmaceutical giants are conducting extensive R&D activities to develop novel vaccines, treatment approaches, and testing kits for this pandemic. These rigorous R&D activities for the development of novel vaccine and treatment approaches have significantly increased demand for research antibodies. Furthermore, several private and government organizations are taking drastic initiatives to support the development of COVID-19 vaccines and therapeutics. In 2020, GlaxoSmithKline invested USD 250 million in Vir Biotechnologies, a San Francisco-based clinical-stage immunology company, to support its antibody-drug development program for COVID-19.

Gather more insights about the market drivers, restrains and growth of the Global Research Antibodies Market

Similarly, in April 2020, the federal government granted USD 14.5 million to Emergent BioSolutions-a Maryland-based biopharmaceutical company-to work on an antibody-drug trial for COVID-19. However, this pandemic has slowed down the discovery and development activities of biological products for other applications, such as oncology and rare diseases, which may hamper growth up to some extent.

A considerable rise in the number of R&D activities by various biopharmaceutical and pharmaceutical companies to develop innovative products is predominantly driving the market. For instance, in January 2018, Abcam Plc. signed a definitive license agreement with Roche in order to obtain the exclusive rights to Spring Bioscience Corporation’s product portfolio only for research purposes. The product portfolio consists of 243 recombinant rabbit monoclonal antibodies that have been optimized for immunohistochemistry.

Similarly, in February 2019, Immunoprecise Antibodies Ltd. in collaboration with the Foundation for Innovative New Diagnostics (FIND) announced the results for their research collaboration project. This project involved the development of rabbit monoclonal antibodies along with the Bcell select platform that helps in recognizing the TB biomarker.

For instance, in October 2019, Y-Biologics and Pascal Biosciences Inc. signed a collaborative research agreement aimed towards facilitating the discovery and development of various novel bio-specific antibodies. As per the agreement, Y-Biologics will be contributing ALiCE, its novel antibody platform technology, and Pascal Biosciences Inc. will be utilizing the company’s antibody products. Increasing funds provided by government bodies for proteomics and genomics research is another factor anticipated to boost market growth during the forecast period.

Browse through Grand View Research's Biotechnology Industry Research Reports

  • Immunohistochemistry Market: The global immunohistochemistry market size was valued at USD 1.28 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2021 to 2028.
  • Flow Cytometry Market : The global flow cytometry market size was valued at USD 6.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.9% from 2021 to 2027.

Research Antibodies Market Segmentation

Grand View Research has segmented the global research antibodies market report on the basis of product, type, technology, source, application, end-use, and region:

  • Research Antibodies Product Outlook (Revenue, USD Million, 2018 - 2028)
    • Primary
    • Secondary
  • Research Antibodies Type Outlook (Revenue, USD Million, 2018 - 2028)
    • Monoclonal Antibodies
    • Polyclonal Antibodies
  • Research Antibodies Technology Outlook (Revenue, USD Million, 2018 - 2028)
    • Immunohistochemistry
    • Immunofluorescence
    • Western Blotting
    • Flow Cytometry
    • Immunoprecipitation
    • ELISA
    • Other Technologies
  • Research Antibodies Source Outlook (Revenue, USD Million, 2018 - 2028)
    • Mouse
    • Rabbit
    • Goat
    • Other Sources
  • Research Antibodies Application Outlook (Revenue, USD Million, 2018 - 2028)
    • Infectious Diseases
    • Immunology
    • Oncology
    • Stem Cells
    • Neurobiology
    • Other Applications
  • Research Antibodies End-use Outlook (Revenue, USD Million, 2018 - 2028)
    • Academic & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Research Antibodies Regional Outlook (Revenue, USD Million, 2018 - 2028)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa (MEA)

Market Share Insights

  • September 2018: Thermo Fisher Scientific Inc., collaborated with Montreal Neurological Institute with an aim to develop improved and new methods to both characterize and produce antibodies for advanced neurological research 

 

Key Companies profiled:

Some of the prominent players in the research antibodies market include:

  • Abcam Plc
  • Bio-rad Laboratories
  • Becton Dickinson & Company
  • Merck Millipore
  • Lonza Group
  • Thermo Fisher Scientific, Inc.
  • Cell Signalling Technology, Inc.
  • Hoffmann La Roche Ltd.
  • Agilent Technologies
  • Perkinelmer, Inc.

 

Order a free sample PDF of the Research Antibodies Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Comments

Post a Comment

Popular posts from this blog

Global Potash Market: Trends, Growth & Forecast 2023-2032

T he global  potash market  size is expected to reach USD 93.50 billion by 2032, growing at a CAGR of 4.9% from 2023 to 2032, according to a new study by Grand View Research, Inc. This is attributed to the increasing demand for food and efficient usage of agricultural land. As consumers seek healthier options, there has been a surge in demand for high-value crops like fruits, vegetables, and specialty crops, boosting the demand for potash. Furthermore, the adoption of precision agriculture techniques has become increasingly prevalent in recent years. Precision agriculture involves using advanced technologies and data-driven approaches, such as soil testing and targeted nutrient management, to make informed decisions about fertilizer application.   Farmers are embracing precise and site-specific methods for applying fertilizers, based on field variability and crop requirements. This trend makes way for optimized resource utilization, improved crop performance, and enhanced...
Read more

Smart Ticketing Market Report: Emerging Technologies & Market Opportunities

  The global smart ticketing market size is expected to reach USD 31.65 billion by 2030, growing at a CAGR of 15.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. With the widespread adoption of smartphones, mobile ticketing channels have gained traction, allowing users to purchase, store, and validate tickets directly on their mobile devices, eliminating the need for physical cards or paper tickets. The convenience and ease of use offered by mobile ticketing have contributed to the growth of the market. Smart ticketing systems generate vast amounts of data on passenger journeys, travel patterns, and ticket usage.   Operators leverage this data to gain valuable insights, optimize operations, and improve the overall passenger experience. Data analytics techniques, such as predictive modeling and real-time monitoring, are being applied to enhance efficiency, manage capacity, and offer personalized services, which bode well for smart ticketing...
Read more

Boosting Crop Yields: India Foliar Fertilizer Market Trends & Forecasts

  The  India foliar fertilizer market  size is expected to reach USD 4.9 billion by 2030, expanding at a CAGR of 11.3% during the forecast period, as per a new report by Grand View Research, Inc. The industry growth is majorly driven by surged demand for food due to increasing population coupled with supportive government initiatives and decreasing arable land in the country.   There has been a significant increase in the global prices of fertilizers and foliar fertilizers. As such, farmers falling into small- and marginal-income categories cannot afford to buy fertilizers resulting in reduced agricultural yields. This has led the Government of India to take initiatives to provide fertilizer subsidies to farmers in the country to make them affordable at subsidized prices. For instance, the Government of India announced a subsidy scheme related to fertilizers worth USD 27 billion in 2022 to ensure that fertilizers are affordable for every farmer in the country. Thus, ...
Read more